Literature DB >> 6085130

Estrogen receptors in human breast cancer detected by the fluorescent estradiol histochemical and dextran coated charcoal techniques.

M Nishiki, K Amano, M Yamane, T Okumichi, H Ezaki.   

Abstract

Surgical specimens from 60 Japanese women with breast cancer were studied histochemically to detect estrogen receptors (ER). Forty-six were analyzed in a double blind study designed to compare the histochemical method using fluorescent estradiol conjugate for detection of ER (FITC method) with findings in case of the currently employed dextran coated charcoal (DCC method) techniques. The ER test was positive in 39 (65 percent) of the 60 cases studied by FITC method. Of the 46 cases analysed in a double blind study, 41 (89.8 percent) showed the same results. Of the 5 with inconsistent test results, 2 showed positive DCC and negative FITC, and 3, negative DCC and positive FITC. According to the histologic type, the FITC method demonstrated a low positive ER response rate in scirrhous cases (57 per cent), whereas the positive rate was 67 percent among papillotubular-type cases and 65 percent among medullary tubular-type cases. In relation to menstrual status, the positive rates were 68 percent and 64 percent among premenopausal and postmenopausal women, respectively. However, in relation to tumor size, no difference was noted in the positive response rate by either method. Therefore, both the DCC and FITC methods are clinically useful to determine the indications for hormone therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085130     DOI: 10.1007/bf02469787

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  18 in total

1.  Current status of estrogen receptors in human breast cancer.

Authors:  W L McGuire
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer.

Authors:  D P Byar; M E Sears; W L McGuire
Journal:  Eur J Cancer       Date:  1979-03       Impact factor: 9.162

3.  Cytochemical study of estrogen receptor in human mammary cancer.

Authors:  S H Lee
Journal:  Am J Clin Pathol       Date:  1978-08       Impact factor: 2.493

4.  The histopathological evaluation of human breast cancers in correlation with estrogen receptor values.

Authors:  F F Parl; R K Wagner
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

5.  An improved histochemical method for detection of estrogen receptors in mammary cancer. Comparison with biochemical assay.

Authors:  L P Pertschuk; E Gaetjens; A C Carter; D J Brigati; D S Kim; T E Fealey
Journal:  Am J Clin Pathol       Date:  1979-05       Impact factor: 2.493

6.  Immunofluorescent detection of estrogen receptors in breast cancer. Comparison with dextran-coated charcoal and sucrose gradient assays.

Authors:  L P Pertschuk; E H Tobin; D J Brigati; D S Kim; N D Bloom; E Gaetjens; P J Berman; A C Carter; G A Degenshein
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

7.  Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer.

Authors:  M J Straus; R Moran; R E Muller; H H Wotiz
Journal:  Oncology       Date:  1982       Impact factor: 2.935

8.  Estrogen receptor analysis on needle aspirates from human mammary carcinoma.

Authors:  C Silfverswärd; S Humla
Journal:  Acta Cytol       Date:  1980 Jan-Feb       Impact factor: 2.319

9.  Cellular localization of estrogen binding sites in human breast cancer.

Authors:  W Hanna; D E Ryder; B G Mobbs
Journal:  Am J Clin Pathol       Date:  1982-04       Impact factor: 2.493

10.  Improved estrogen receptor assay in human mammary cancer. Technics for handling small tissue samples.

Authors:  R B Johnson; R M Nakamura
Journal:  Am J Clin Pathol       Date:  1977-05       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.